Alagebrium: Benefit on Peripheral Arteries

Journal of Cardiac Failure

Volumn 12, Issue 7, 2006, Pages 584-

  O'Rourke, Michael F ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALAGEBRIUM;

ARTERY; CLINICAL PRACTICE; DIASTOLE; HEART FAILURE; HEART LEFT VENTRICLE MASS; HEART VENTRICLE FILLING; LETTER; PRIORITY JOURNAL; PULSE PRESSURE; QUALITY OF LIFE; SYSTOLIC BLOOD PRESSURE;

ARTERIES; CARDIAC OUTPUT, LOW; HUMANS; THIAZOLES;

EID: 33748098517     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2006.06.474     Document Type: Letter

References (4)

1. Little W.C., Zile M.A., Kitzman D.W., Hundley W.C., O'Brien T.X., and Degroof R.C. The effect of alagebrium chloride (ALT711), a novel glucose cross-link breaker, in the treatment of elderly patients with diastolic heart failure. J Card Fail 11 (2005) 191-195
2. Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A. Collier D, et al. CAFÉ investigators; Anglo-Scandinavian Cardiac Outcomes Trial Investigators; CAFÉ Steering Committee and Writing Committee. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006;113:1213-25.
3. London G.M., Asmar R.G., O'Rourke M.F., Safar M.E., and REASON Project Investigators. Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: comparison with atenolol. J Am Coll Cardiol 43 (2004) 92-99
4. Kass D.A., Shapiro E.P., Kawaguchi M., Capriotti A.R., Scuteri A., deGroof R.C., et al. Improved arterial compliance by a novel advanced glycation end-product crosslink breaker. Circulation 104 (2001) 1464-1470